Novavax Reports Q3 2026 Revenue of $68 Million
Novavax reported $68 million in revenue for the third quarter of 2026. The body says the company raised its full-year 2026 non-GAAP outlook, but the figure is truncated.
Story updates
01:06:02 PM UTC
SquawkNews
*-- Earnings Flash (NVAX) Novavax, Inc. Reports Q3 Revenue $68.3M, vs.